• Loading stock data…

Genenta to Present at Upcoming Scientific Congresses ASGCT, BTM, ASCO and EHA

Last Updated on May 13, 2022 by GlobeNewsWire

MILAN, Italy and NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, will be presenting at several upcoming scientific congresses in May and June.




Print Friendly, PDF & Email
Spread the word

Reader Interactions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: